April 9th, 2011

And Now, for a More Comprehensive CROI Report …

Although I’ve already provided a Really Rapid Review™ of the 18th Conference on Retroviruses and Opportunistic Infections (CROI), the editors of Journal Watch/AIDS Clinical Care have put together a more comprehensive summary here.

I sometimes wonder what research from these conferences will not only stand the test of time, but will grow in importance and be viewed one day as a landmark event.

Past notable examples include the first triple-therapy study with indinavir — which showed that virologic suppression could be durable — presented way back in 1996 at the 3rd CROI, and the phase III study of raltegravir in patients with highly drug-resistant virus, presented 11 years later at CROI 14.

My bet this time?  While it’s notoriously tough to make predictions, especially about the future, my vote goes to these zinc finger nuclease studies — which are part of a very concerted and growing effort to cure HIV.

Comments are closed.

HIV Information: Author Paul Sax, M.D.

Paul E. Sax, MD

Contributing Editor

NEJM Journal Watch
Infectious Diseases

Biography | Disclosures | Summaries

Learn more about HIV and ID Observations.